Free database of papers and journals






Results 1 to 20 of 94 articles found
2002

Tadalafil Phase 3 Experience

European Urology Supplement (0.1 31), 1, 25-30.
2003

Long-term safety experience with tadalafil

European Urology Supplement (0.1 31), 2, 96.
2010

S117 TADALAFIL DAILY OR ON DEMAND THERAPY?

European Urology Supplement (0.1 31), 9, 587.
2019

Therapeutic effect of tadalafil in the chronic prostatitis

European Urology Supplement (0.1 31), 18, e1978.
2003

Pharmacodynamic interactions between tadalafil and nitrates compared with sildenafil

European Urology Supplement (0.1 31), 2, 95.
2015

81 Protective effect of tadalafil on unilateral ureter obstruction

European Urology Supplement (0.1 31), 14, e1395.
2014

S218: The early effects of daily tadalafil on the uroflowmetric parameters

European Urology Supplement (0.1 31), 13, e1546.
2006

TADALAFIL IN MEN WITH ERECTILE DYSFUNCTION AND SPINAL CORD INJURY

European Urology Supplement (0.1 31), 5, 179.
2014

602 A comparison of baseline erectile function after on-demand 20 mg tadalafil vs daily 5 mg tadalafil in men with erectile dysfunction and diabetes: A prospective, observational 2-year study

European Urology Supplement (0.1 31), 13, e602.
2017

Daily tadalafil therapy: A new treatment option for Peyronie’s disease?

European Urology Supplement (0.1 31), 16, e667.
2005

536Rechallenging non-responders to tadalafil and vardenafil: A real-life study

European Urology Supplement (0.1 31), 4, 136.
2019

A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of overactive bladder associated with benign prostatic hyperplasia (CONTACT Study)

European Urology Supplement (0.1 31), 18, e256.
2002

Dose-normalised pharmacokinetics of tadalafil administered as a single dose to healthy volunteers

European Urology Supplement (0.1 31), 1, 152.
2013

652 Effect of Tadalafil and Diltiazem on ESWL induced kidney injury in rats

European Urology Supplement (0.1 31), 12, e652-e653.
2016

What is the current situation in lower urinary tract symptoms with daily tadalafil?

European Urology Supplement (0.1 31), 15, e1311.
2015

171 In sepsis model formed on rats, does tadalafil protect from renal injury?

European Urology Supplement (0.1 31), 14, e1445.
2008

COMBINATION OF ALFUZOSIN AND TADALAFIL EXERTS ADDITIVE RELAXANT EFFECT ON HUMAN PROSTATE

European Urology Supplement (0.1 31), 7, 95.
2018

Comparison between nanotechnology structured water (magnalife) and tadalafil for the treatment of erectile dysfunction

European Urology Supplement (0.1 31), 17, e853.
2009

373 EVALUATION OF THE EFFICACY AND SAFETY OF TADALAFIL 20 MG ON DEMAND VS. TADALAFIL 5 MG ONCE-A-DAY IN THE TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING CURATIVE RADIOTHERAPY FOR PROSTATIC CARCINOMA: PRELIMINARY RESULTS OF A RANDOMIZED PHASE II TRIAL

European Urology Supplement (0.1 31), 8, 214.
2004

99 The two PDE 5 inhibitors sildenafil and tadalafil-results of an independent intraindividual comparative trial

European Urology Supplement (0.1 31), 3, 27.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions